Safety of Palivizumab Stewardship in Conjunction with Infection Prevention and Control Strategies for Healthcare-Associated Respiratory Syncytial Virus Infections. (21st February 2018)

• Record Type: Journal Article
• Authors: Patel, Rupal M.; Kociolek, Larry K.; Merrick, Emily; Reuter, Caroline; Kronforst, Kenny; Zheng, Xiaotian; Patel, Sameer J.
• Is Part Of: Infection control and hospital epidemiology. Volume 39:Number 4(2018)
• Page Start: 485
• Page End: 487
• Publication Date: 2018-02-21
• Subjects: Nosocomial infections -- Epidemiology -- Periodicals; Health facilities -- Sanitation -- Periodicals; Hospital buildings -- Sanitation -- Periodicals; Cross Infection -- Periodicals; Epidemiology -- Periodicals; Hospitals -- Periodicals; Infection Control -- Periodicals; 614.44
• DOI: 10.1017/ice.2017.328
• Languages: English
• ISSNs: 0899-823X

Abstract

ABSTRACT: Transitioning from administration of monthly palivizumab to a single dose at discharge was associated with substantial pharmacy cost savings. With the concurrent adoption of private hospital rooms and visitor restriction policies, hospital-wide and neonatal intensive care unit healthcare-associated respiratory syncytial virus infections decreased following these changes. Infect Control Hosp Epidemiol 2018;39:485–487